Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Intra-Cellular Therapies, Inc. (ITCI)
Sector: Healthcare; Industry: Biotechnology

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS) in the United States. It is also developing ITI-002 that inhibits the enzyme phosphodiesterase type 1; ITI-214 for Parkinson's disease; and ITI-333, for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-01-11 Durgam Suresh K. Chief Medical Officer Sell 4,367 $32.12 $140,259 Yes
2021-01-11 Neumann Mark EVP, Chief Commercial Officer Sell 9,684 $32.02 $310,082 Yes
2021-01-11 Hineline Lawrence J. SVP of Finance CFO Sell 19,638 $32.02 $628,769 Yes
2021-01-11 Halstead Michael EVP and General Counsel Sell 19,638 $32.03 $628,978 Yes
2021-01-11 Mates Sharon Chairman, President & CEO Sell 41,896 $32.01 $1,341,260 Yes
2021-01-04 Hineline Lawrence J. SVP of Finance CFO Sell 15,810 $31.31 $495,008 Yes
2021-01-04 Halstead Michael EVP and General Counsel Sell 16,160 $31.30 $505,834 Yes
2021-01-04 Mates Sharon Chairman, President & CEO Sell 48,341 $31.30 $1,513,271 Yes
2020-11-17 Halstead Michael EVP and General Counsel Sell 79,425 $27.62 $2,193,446 Yes
2020-11-11 Hineline Lawrence J. SVP of Finance CFO Sell 28,034 $25.41 $712,344 Yes
2020-11-10 Mates Sharon Chairman, President & CEO Sell 50,000 $26.34 $1,317,101 No
2020-11-04 Mates Sharon Chairman, President & CEO Sell 50,000 $25.00 $1,250,000 No
2020-10-16 Neumann Mark EVP, Chief Commercial Officer Sell 6,792 $26.80 $182,026 Yes
2020-09-14 Alafi Christopher D Director Buy 49,500 $29.60 $1,465,200 No
2020-09-09 Hineline Lawrence J. SVP of Finance CFO Sell 41,983 $31.14 $1,307,351 Yes
2020-09-11 Alafi Christopher D Director Buy 21,000 $28.08 $589,680 No
2020-05-14 MARCUS JOEL S Director Sell 9,602 $20.04 $192,424 No
2020-05-13 MARCUS JOEL S Director Sell 57,297 $20.04 $1,148,037 No
2020-05-11 LERNER RICHARD A Director Sell 3,500 $20.50 $71,750 Yes
2020-01-09 Satlin Andrew EVP and Chief Medical Officer Sell 11,573 $26.16 $302,750 Yes
2020-01-09 Mates Sharon Chairman, President & CEO Sell 41,895 $26.16 $1,095,973 No
2020-01-09 Halstead Michael EVP and General Counsel Sell 19,638 $26.16 $513,730 No
2020-01-09 Hineline Lawrence J. SVP of Finance CFO Sell 19,638 $26.16 $513,730 No
2020-01-08 Mates Sharon Chairman, President & CEO Sell 45,598 $30.28 $1,380,880 Yes
2020-01-06 Halstead Michael EVP and General Counsel Sell 21,458 $30.34 $651,007 Yes
2020-01-06 Hineline Lawrence J. SVP of Finance CFO Sell 21,458 $30.29 $650,003 Yes
2020-01-02 Halstead Michael EVP and General Counsel Sell 7,807 $32.43 $253,214 Yes
2020-01-02 Hineline Lawrence J. SVP of Finance CFO Sell 7,807 $32.43 $253,165 Yes
2020-01-02 Mates Sharon Chairman, President & CEO Sell 17,478 $32.45 $567,230 Yes
2019-12-23 Hineline Lawrence J. SVP of Finance CFO Sell 15,032 $25.50 $383,316 Yes

Insider Smart

VBI Vaccines Inc (VBIV) - Since 10%-owner Perceptive Advisor LCC increased their holding in April, the stock have double the price. Impressive!

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?